JPRN-jRCT2080222812未知1 期
A Phase I Study in Resminostat monotherapy and S-1/Resminostat therapy in Patients with biliary tract or pancreatic cancer
试验速览
- 阶段
- 1 期
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •(1)Patients with unresectable/recurrence biliary tract cancer (intrahepatic cholangiocarcinoma, extrahepatic bile duct carcinoma, gallbladder carcinoma and ampulla of Vater carcinoma) or unresectable/recurrence pancreatic cancer
- •(2)Patients who have received more than one regimen systemic chemotherapy history for biliary tract cancer or pancreatic cancer
- •(3)Patients with an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1
- •(4)Patients who are able to ingest resminostat orally and have no gastrointestinal disturbance that, in the judgment of the investigator, may affect the absorption of resminostat
排除标准
- •(1)Patients who have taken HDAC inhibitor
- •(2)Pregnant women or lactating mothers
- •(3)Patients with brain metastases or suspected brain metastases based on the clinical symptoms
研究者
相似试验
已完成
1 期
Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)Hepatocellular CarcinomaNCT02400788Yakult Honsha Co., LTD179
已完成
1 期
A Clinical trial for Resminostat to Investigate the Effect of FoodJPRN-jRCT2071210134Asami Tsubasa12
招募中
2 期
Phase II study of S-1 monotherapy as 1st line chemotherapy in patients > or = 80 with advanced non-small cell lung cancerpatients >or = 80 with advanced non-small cell lung cancerJPRN-UMIN000008490Shinshu University Hospital35
已完成
不适用
A phase 1 clinical pharmacological study with repeated oral doses of KAG-308lcerative ColitisJPRN-UMIN000014009Kaken Pharmaceutical Co., LTD30
招募中
1 期
A Phase 1 Study of Lomustine and PCV in Japanese Patients with GliomaGliomaJPRN-jRCT2051230069ARAKAWA Yoshiki24